ICD-10-CM Billable Code

D02.2

Carcinoma in situ of bronchus and lung

Clinical Classification Guidelines

Medical Intelligence & Overview

Carcinoma in situ of the bronchus and lung, classified under ICD-10 code D02.2, refers to a type of early-stage lung cancer where abnormal cells are present in the lining of the bronchus or lung. The term 'carcinoma in situ' indicates that the abnormal cells have not yet invaded deeper layers or spread to other parts of the body. Recognizing this condition in its early stages is important for management and potential treatment options. Although it is considered a pre-cancerous condition, without proper care, it may develop into invasive lung cancer over time.

Causes & Symptoms

Clinical Causes: Long-term exposure to tobacco smoke is the primary risk factor. Exposure to radon gas, a naturally occurring radioactive substance. Occupational exposure to carcinogens such as asbestos, arsenic, or diesel exhaust. Environmental pollutant exposure, including air pollution. Family history of lung cancer or other related cancers. Existing lung diseases, such as chronic obstructive pulmonary disease (COPD).

Key Symptoms: Persistent cough that does not resolve. Coughing up blood or blood-stained sputum. Shortness of breath or wheezing. Chest pain or discomfort. Recurring respiratory infections. Unexplained weight loss or fatigue (in more advanced cases).

Diagnostic & Treatment

Diagnosis Path: Diagnosis of carcinoma in situ of the bronchus and lung involves several diagnostic procedures, including: - Imaging tests such as chest X-rays and computed tomography (CT) scans to identify abnormal areas. - Bronchoscopy, a procedure where a thin tube with a camera is inserted into the airways to visualize and biopsy suspicious lesions. - Histopathological examination of tissue samples obtained through biopsy to confirm the presence of carcinoma in situ. - Additional tests might include sputum cytology or molecular testing for genetic markers.

Treatment Protocols: Treatment options depend on the size, location, and overall health of the patient. Common approaches include: - Surgical removal of the affected part of the bronchus or lung if the lesion is localized. - Monitoring with close follow-up if the lesion is small or not causing symptoms, with interventions planned if progression occurs. - Consideration of minimally invasive techniques such as bronchoscopic ablation for suitable cases. - The role of chemotherapy and radiation therapy for cases where surgical options are limited or for invasive disease that develops from carcinoma in situ. - Preventive measures, including cessation of smoking and avoiding environmental carcinogens, are crucial to reduce risk factors.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is D02.2 a billable ICD-10 code?
Yes, D02.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report D02.2?
Clinical documentation must specify the nature of Carcinoma in situ of bronchus and lung and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

bronchus carcinoma